Crizotinib Capsules
Anticancer Medicine / Targeted Therapy
Crizotinib Capsules
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Crizotinib Capsules (Crizokast). High-quality, reliable, affordable medicine.
Formulation
Capsules
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
Finished Commercial Brand
Available finished formulation under our brand name Crizokast 250mg.
View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Crizotinib Capsules
Classification: Anticancer Medicine / Targeted Therapy
About Crizotinib Capsules
Crizotinib is a targeted kinase inhibitor medication used in the treatment of ALK-positive and ROS1-positive non-small cell lung cancer (NSCLC), inhibiting abnormal proteins that signal cancer cells to multiply.
Crizotinib Capsules (Crizokast) Manufactured by Aprazer Healthcare
Crizokast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.